BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16626152)

  • 1. Synthesis of new sugar-based surfactants and evaluation of their hemolytic activities.
    Neimert-Andersson K; Sauer S; Panknin O; Borg T; Söderlind E; Somfai P
    J Org Chem; 2006 Apr; 71(9):3623-6. PubMed ID: 16626152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic activity and solubilizing capacity of raffinose and melezitose fatty acid monoesters prepared by enzymatic synthesis.
    Carvalho L; Morales JC; Pérez-Victoria JM; Pérez-Victoria I
    Eur J Pharm Biopharm; 2015 May; 92():139-45. PubMed ID: 25753196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of sugar surfactants as solubilizing agents in parenteral formulations.
    Söderlind E; Wollbratt M; von Corswant C
    Int J Pharm; 2003 Feb; 252(1-2):61-71. PubMed ID: 12550781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic surfactants derived from lysine: effects of their structure and charge type on antimicrobial and hemolytic activities.
    Colomer A; Pinazo A; Manresa MA; Vinardell MP; Mitjans M; Infante MR; Pérez L
    J Med Chem; 2011 Feb; 54(4):989-1002. PubMed ID: 21229984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery.
    Wang XL; Ramusovic S; Nguyen T; Lu ZR
    Bioconjug Chem; 2007; 18(6):2169-77. PubMed ID: 17939730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic activity of maltopyranoside surfactants.
    Söderlind E; Karlsson L
    Eur J Pharm Biopharm; 2006 Apr; 62(3):254-9. PubMed ID: 16274978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug solubilization and in vitro toxicity evaluation of lipoamino acid surfactants.
    Ménard N; Tsapis N; Poirier C; Arnauld T; Moine L; Lefoulon F; Péan JM; Fattal E
    Int J Pharm; 2012 Feb; 423(2):312-20. PubMed ID: 22143086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis and antihemolysis induced by amino acid-based surfactants.
    Sánchez L; Martínez V; Infante MR; Mitjans M; Vinardell MP
    Toxicol Lett; 2007 Mar; 169(2):177-84. PubMed ID: 17293064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of sugar-based chelating surfactants for metal removal from wastewater.
    Ferlin N; Grassi D; Ojeda C; Castro MJ; Grand E; Cirelli AF; Kovensky J
    Carbohydr Res; 2008 Apr; 343(5):839-47. PubMed ID: 18282560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying the hydrophobic effect. 2. A computer simulation-molecular-thermodynamic model for the micellization of nonionic surfactants in aqueous solution.
    Stephenson BC; Goldsipe A; Beers KJ; Blankschtein D
    J Phys Chem B; 2007 Feb; 111(5):1045-62. PubMed ID: 17266258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel highly fluorinated sulfamates: synthesis and evaluation of their surfactant properties.
    Debbabi K; Guittard F; Geribaldi S
    J Colloid Interface Sci; 2008 Oct; 326(1):235-9. PubMed ID: 18687443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The hemolysis and solubilization behavior of nonionic polymer surface-active agents classes].
    Reinhart T; Bauer KH
    Pharmazie; 1995 Jun; 50(6):403-7. PubMed ID: 7544467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies of the hemolytic activity of microemulsions in human erythrocytes.
    Aparicio RM; José García-Celma M; Pilar Vinardell M; Mitjans M
    J Pharm Biomed Anal; 2005 Oct; 39(5):1063-7. PubMed ID: 16054795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydrophobic modification of polyelectrolytes as solubility enhancers in preparations for parenteral administration].
    Eisenmann G; Bauer KH
    Pharmazie; 1995 Mar; 50(3):191-4. PubMed ID: 7732050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new physiologically approached in vitro test for quick evaluation of the hemolytic activity of surfactants.
    Stenz R; Bauer KH
    Pharmazie; 1996 May; 51(5):283-7. PubMed ID: 8710952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of novel, nonhemolytic surfactants with phospholipid vesicles.
    Thorén PE; Söderman O; Engström S; von Corswant C
    Langmuir; 2007 Jun; 23(13):6956-65. PubMed ID: 17516668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and properties of new bolaform and macrocyclic galactose-based surfactants obtained by olefin metathesis.
    Satgé C; Granet R; Verneuil B; Champavier Y; Krausz P
    Carbohydr Res; 2004 May; 339(7):1243-54. PubMed ID: 15113661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization and toxicity evaluation of steroid-based surfactants designed for solubilization of poorly soluble drugs.
    Ménard N; Tsapis N; Poirier C; Arnauld T; Moine L; Lefoulon F; Péan JM; Fattal E
    Eur J Pharm Sci; 2011 Dec; 44(5):595-601. PubMed ID: 22019523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the interactions between dendrimers and surfactants: 2. Design of new drug formulations based on dendrimer-surfactant aggregates.
    Cheng Y; Wu Q; Li Y; Hu J; Xu T
    J Phys Chem B; 2009 Jun; 113(24):8339-46. PubMed ID: 19469491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and properties of new glucocationic surfactants: model structures for marking cationic surfactants with carbohydrates.
    Quagliotto P; Viscardi G; Barolo C; D'Angelo D; Barni E; Compari C; Duce E; Fisicaro E
    J Org Chem; 2005 Nov; 70(24):9857-66. PubMed ID: 16292816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.